Evidence map›Paper›PMID 35011609›Full record

ArticleCells2021

KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain.

Rijwan Uddin Ahammad, Tomoki Nishioka, Junichiro Yoshimoto, Takayuki Kannon, Mutsuki Amano, Yasuhiro Funahashi, Daisuke Tsuboi, Md Omar Faruk, Yukie Yamahashi, Kiyofumi Yamada and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Rijwan Uddin AhammadDepartment of Cell Pharmacology, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Nagoya 466-8550, Japan.ORCID 0000-0002-1387-1943
Tomoki NishiokaInstitute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan.
Junichiro YoshimotoDivision of Information Science, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma 630-0192, Japan.ORCID 0000-0001-7995-0321
Takayuki KannonDepartment of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Science, Kanazawa University, Kanazawa 920-8640, Japan.ORCID 0000-0001-9866-1621
Mutsuki AmanoDepartment of Cell Pharmacology, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Nagoya 466-8550, Japan.ORCID 0000-0002-0662-1524
Yasuhiro FunahashiInstitute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0002-0559-4763
Daisuke TsuboiInstitute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan.
Md Omar FarukDepartment of Cell Pharmacology, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Nagoya 466-8550, Japan.
Yukie YamahashiInstitute for Comprehensive Medical Science, Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0003-3697-0861
Kiyofumi YamadaDepartment of Neuropsychopharmacology and Hospital Pharmacy, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Nagoya 466-8550, Japan.
Taku NagaiDivision of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake 470-1192, Japan.ORCID 0000-0001-5050-7748
Kozo KaibuchiDepartment of Cell Pharmacology, Graduate School of Medicine, Nagoya University, 65 Tsurumai, Nagoya 466-8550, Japan.
Fujita Health University · JPNagoya University · JPKanazawa University · JPNagoya University Hospital · JPNara Institute of Science and Technology · JP

Funding

Japan Agency for Medical Research and Development JP18dm0207005, JP21dm0207075, JP21wm0425017 and JP21wm0425008Japan Society for the Promotion of Science JP16K18393, JP17H01380, JP17K07383, JP17H02220, JP17K19483, JP18K14849, JP19K16370, JP21K06428 and JP21K06427Ministry of Education, Culture, Sports, Science and Technology JP17H05561, JP19H05209 and JP21H00196
6 · The paper itself

Abstract

Protein phosphorylation plays critical roles in a variety of intracellular signaling pathways and physiological functions that are controlled by neurotransmitters and neuromodulators in the brain. Dysregulation of these signaling pathways has been implicated in neurodevelopmental disorders, including autism spectrum disorder, attention deficit hyperactivity disorder and schizophrenia. While recent advances in mass spectrometry-based proteomics have allowed us to identify approximately 280,000 phosphorylation sites, it remains largely unknown which sites are phosphorylated by which kinases. To overcome this issue, previously, we developed methods for comprehensive screening of the target substrates of given kinases, such as PKA and Rho-kinase, upon stimulation by extracellular signals and identified many candidate substrates for specific kinases and their phosphorylation sites. Here, we developed a novel online database to provide information about the phosphorylation signals identified by our methods, as well as those previously reported in the literature. The "KANPHOS" (Kinase-Associated Neural Phospho-Signaling) database and its web portal were built based on a next-generation XooNIps neuroinformatics tool. To explore the functionality of the KANPHOS database, we obtained phosphoproteomics data for adenosine-A2A-receptor signaling and its downstream MAPK-mediated signaling in the striatum/nucleus accumbens, registered them in KANPHOS, and analyzed the related pathways.

Indexed as

Databases, ProteinAnimalsBrainCalcium ChannelsMaleMAP Kinase Signaling SystemMiceMice, Inbred C57BLNeuronsPhosphoproteinsPhosphorylationProtein KinasesReceptor, Adenosine A2ASubstrate SpecificityCalcium ChannelsPhosphoproteinsProtein KinasesReceptor, Adenosine A2Aadenosine signalingintellectual disabilityKANPHOSmolecular mechanismneurodevelopmental disordersphosphoproteomicsphosphorylationsignal transduction

Identifiers

PMID35011609
PMCPMC8750479
OpenAlexW4200258579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.